Stem cell trial can re-start

August 2, 2010
Research and Development Geron, Stem cells, spinal injury, stem cell

US regulators have given the green light for the first human trial of an embryonic stem cell therapy to resume. …

Working with a changing NHS

August 2, 2010
Sales and Marketing HCA, NHS, commissioning, market access

The first Healthcare Communications Association (HCA) forum of 2010 took place this April in London and looked at the central …

Ben_Mansfield_Marie_Pickford

Doctors.net.uk boosts team

August 2, 2010
Sales and Marketing appointment, doctors.net, sales and marketing

UK healthcare professional network Doctors.net.uk has appointed Marie Pickford and Ben Mansfield to its pharmaceutical team. Marie joins in a …

Amgen's Prolia

NICE halts Prolia appraisal

August 2, 2010
Sales and Marketing Amgen, NICE, Prolia

NICE says it has been forced to terminate a review of Amgenโ€™s bone density drug Prolia after the US biotech …

Blog footer

Digital Pharma: Novartis game takes aim at ticks

July 30, 2010
Medical Communications Digital Pharma blog, Novartis, digital patients, disease awareness campaigns, encephalitis

Novartis has launched a new online game to raise awareness of the risks posed by ticks and how to avoid …

Dean_Russell

Fleishman-Hillard adds new digital director

July 30, 2010
Medical Communications Fleishman, appointment, medical communications

Dean Russell has joined Fleishman-Hillard London as its new director of digital. He has a wealth of experience in developing …

Indian flag

Wellcome Trust signs ยฃ45m Indian collaboration

July 30, 2010
Research and Development India, Wellcome, em, emerging markets

UK medical research charity the Wellcome Trust and the Indian government are to jointly develop a range of innovative and …

Cancer Research UK facility celebrates first GMP batch

July 30, 2010
Manufacturing and Production Biotherapeutic, Cancer Research UK, biologics

Cancer Research UK has produced the first batch of product from its recently-completed biologics manufacturing unit, and hopes to release …

FDA recommends Brilinta

July 30, 2010
Sales and Marketing 2010 financials, AstraZeneca, Brillinta, Q2

FDA advisors have voted in favour of AstraZenecaโ€™s antiplatelet drug Brilinta, which is currently seeking a licence for the reduction …

Dr Bruce Burlington joins AZ board

July 30, 2010
Research and Development, Sales and Marketing AstraZeneca, appointment, research and development, sales and marketing

AstraZeneca has appointed former FDA staffer Dr Bruce Burlington to its board as a non-executive director. Dr Burlington spent 17 …

JWT wins Pfizer account, denies it’s ‘Viagra 2’

July 30, 2010
Medical Communications JWT, Pfizer, viagra

UK advertising agency JWT London has won an account from Pfizer, but played down media reports it had been appointed …

Sanofi’s blockbusters take a hit

July 29, 2010
Sales and Marketing 2010 financials, Genzyme, Q2, Sanofi-Aventis

Generic pressures, European pricing pressures and the impact of the US health reforms combined to dent Sanofi-Aventisโ€™s growth in the …

Contract research news in brief

July 29, 2010
Research and Development CRO, LAB Research, Microsoft, PPD, PharmaNet, QPS, Selvita

Icon reports that new business wins rose healthily in the second quarter, plus thereโ€™s an alliance between PPD and Microsoft …

RSA expands European teams

July 29, 2010
Business Services appointment, business services, rsa

Life sciences executive search and interim management firm RSA has made series of new appointments to some of the European …

Robert Thomson joins Photosound

July 29, 2010
Medical Communications Photosound, appointment, medical communications

UK brand communcations agency Photosound has appointed Robert Thomson as head of digital product development. He has over 15 yearsโ€™ …

Cardio3 BioSciences appoints Dr Atta Behfar

July 29, 2010
Research and Development Cardio3, appointment, research and development

Belgium biotech company Cardio3 BioSciences has appointed Dr Atta Behfar as director for advanced research. He will spend a year …

UK lags behind Europe on innovative cancer drugs

July 29, 2010
Sales and Marketing Cancer, market access

The UK has been ranked as one of the worst countries when it comes to uptake of new cancer drug …

Merck KGaA’s oral MS therapy gains US priority review

July 29, 2010
Sales and Marketing Cladribine, MS, Merck KGaA

Merckโ€™s cladribine has been granted a priority review status by the FDA in a move that could see it come …

Chiltern Announces its Financial Results for the Year Ended 31 March 2010

July 28, 2010
Research and Development

Highlightsโ€ข Revenues of ยฃ80.9 million, 9.8% ahead of the year ended March 2009. Of this, 1.5% is due to acquisitions, …

The Gateway to Local Adoption Series

Latest content